SCHEMBL4932089

SCHEMBL4932089

CCC(C)Nc1cc(C)cc(COc2c(C)cc(NC(=O)CC(=O)O)cc2C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 4/20 0.43
THRA P10827 3/20 0.43
ALDH1A1 P00352 3/20 0.42
KMT2A Q03164 6/20 0.38
MEN1 O00255 5/20 0.38
MCL1 Q07820 1/20 0.38
HTT P42858 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
POLB P06746 1/20 0.36
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
FFAR4 Q5NUL3 2/20 0.34
FFAR1 O14842 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
TDP1 Q9NUW8 2/20 0.33
USP2 O75604 1/20 0.33
MRGPRX4 Q96LA9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4929827 0.90 THRB (0.46) THRBTHRAALDH1A1KMT2AMEN1
SCHEMBL4924778 0.89 THRB (0.37) THRBTHRAALDH1A1KMT2AMEN1
SCHEMBL4932928 0.89 THRA (0.42) THRBTHRAALDH1A1KMT2AMEN1
SCHEMBL4931042 0.89 THRB (0.44) THRBTHRAKMT2AMEN1MCL1
SCHEMBL4932697 0.87 ALDH1A1 (0.44) THRBTHRAALDH1A1KMT2AMEN1
SCHEMBL5111499 0.86 ALDH1A1 (0.58) THRBTHRAALDH1A1KMT2AMEN1
SCHEMBL5116413 0.85 THRB (0.46) THRBTHRAALDH1A1KMT2AMEN1
SCHEMBL4932767 0.84 ALDH1A1 (0.46) THRBTHRAALDH1A1KMT2AMEN1
SCHEMBL5111642 0.84 KMT2A (0.46) THRBTHRAALDH1A1KMT2AMEN1
SCHEMBL4931960 0.84 ALDH1A1 (0.45) THRBTHRAALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA THRB 4/4885THRA 3/4885ALDH1A1 1818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.